Increasing radiation dose improves immunotherapy outcome and prolongation of tumor dormancy in a subgroup of mice treated for advanced intracerebral melanoma Henry M. SmilowitzPeggy L. MiccaLynn Kuo Original Article 11 December 2015 Pages: 127 - 139
Neutrophil–lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy Ban Seok LeeSang Hyub LeeYong-Tae Kim Original Article 04 January 2016 Pages: 141 - 150
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer Masanori NoguchiFukuko MoriyaKyogo Itoh Original Article 04 January 2016 Pages: 151 - 160
Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study Susanna MandruzzatoSven BrandauSteffen Walter Original Article Open access 04 January 2016 Pages: 161 - 169
Interrogation of individual intratumoral B lymphocytes from lung cancer patients for molecular target discovery Michael J. CampaM. Anthony MoodyEdward F. Patz Jr. Original Article 06 January 2016 Pages: 171 - 180
Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients Anastasia DielmannAnne LetschAntonia Busse Original Article 11 January 2016 Pages: 181 - 192
IL-6 down-regulates HLA class II expression and IL-12 production of human dendritic cells to impair activation of antigen-specific CD4+ T cells Yosuke OhnoHidemitsu KitamuraAkinobu Taketomi Original Article 12 January 2016 Pages: 193 - 204
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy Anirudh SaraswathulaElizabeth A. ReapJohn H. Sampson Original Article 12 January 2016 Pages: 205 - 211
Galectin-1 is associated with poor prognosis in patients with cutaneous head and neck cancer with perineural spread Sharad ChawlaTimothy A. WarrenBenedict J. Panizza Original Article 12 January 2016 Pages: 213 - 222
Poly(I:C) potentiates Bacillus Calmette–Guérin immunotherapy for bladder cancer Cherifa AyariMarjorie BesançonYves Fradet Original Article 12 January 2016 Pages: 223 - 234
8th Annual Canadian Cancer Immunotherapy Consortium (CCIC) Symposium 2015—May 20–22, Vancouver, Canada Jeanette E. BoudreauMaartje C. A. WoutersConnie M. Krawczyk Meeting Report 12 January 2016 Pages: 235 - 241